Full details, including potential risk factors, are given in the Press Release, which can be consulted by clicking on the link below
Nicox Completes Enrollment of the Adaptive Design Cohort of NCX 470 Mont Blanc Phase 3 Glaucoma Trial

September 2, 2020

View Press Release Corporate presentation Contact us
Previous